Sequana Medical NV (SEQUA.BR) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · Belgium · ISIN BE0974340722

Price
0.61 EUR
Market cap
47.76 m EUR
P/E (2024)
–
P/S (2024)
450.60
Dividend yield
0.00 %
Net margin
-42,126.42 %
Return on equity (ROE)
100.62 %
Return on assets (ROA)
-449.05 %

Sequana Medical NV financials

Fiscal year20232024
Revenue712,173.00 EUR106,000.00 EUR
Gross profit548,049.00 EUR-2.22 m EUR
Operating income-29.49 m EUR-18.71 m EUR
EBIT-29.49 m EUR-18.01 m EUR
Net income-32.56 m EUR-44.65 m EUR
Diluted EPS – continuing operations-1.22 EUR-1.22 EUR

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Sequana Medical NV

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 28.04.2026. Details in the risk notice.